April Liwag
Nurse Practitioner · Orange, CANPI 1578007662
Payments from drug & device makers
Across 784 payments — averaging $21.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Vifor Pharma, Inc.$2K
- Travere Therapeutics, Inc.$1K
- Mallinckrodt Hospital Products Inc.$1K
- OPKO Pharmaceuticals, LLC$981
- Bayer$960
- plus $7K from 25 others
What the payments were for
- Food & beverage$16,43099%
- Education$2021%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 147 | $3,458 |
| Vifor Pharma, Inc. | 91 | $1,944 |
| Travere Therapeutics, Inc. | 66 | $1,296 |
| Mallinckrodt Hospital Products Inc. | 62 | $1,175 |
| OPKO Pharmaceuticals, LLC | 64 | $981 |
| Bayer | 42 | $960 |
| Otsuka America Pharmaceutical, Inc. | 40 | $885 |
| Fresenius USA Marketing, Inc. | 39 | $798 |
| Akebia Therapeutics Inc | 35 | $791 |
| Calliditas Therapeutics US Inc. | 26 | $645 |
| Ardelyx, Inc. | 26 | $496 |
| Boehringer Ingelheim | 22 | $422 |
| GSK | 21 | $385 |
| Amgen(2 entities) | 15 | $356 |
| ANI Pharmaceuticals, Inc. | 16 | $349 |
| Novartis | 15 | $333 |
| Lilly USA, LLC | 18 | $234 |
| Daiichi Sankyo Inc. | 5 | $198 |
| Apellis Pharmaceuticals, Inc. | 7 | $178 |
| Veloxis Pharmaceuticals, Inc. | 3 | $157 |
| Scpharmaceuticals Inc. | 5 | $144 |
| Aurinia Pharma U.S., Inc. | 4 | $77 |
| Novo Nordisk | 3 | $72 |
| Sanofi | 2 | $66 |
| Merck | 2 | $52 |
| Chiesi USA, Inc. | 2 | $51 |
| Ultragenyx Pharmaceutical Inc. | 2 | $50 |
| Mannkind Corporation | 1 | $27 |
| Cormedix Inc. | 1 | $23 |
| Abiomed | 1 | $17 |
| Lundbeck LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$230
- LOKELMA$225
- INJECTAFER$123
- Kerendia$107
How this compares
$16,633 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProsolParenteral Amino Acid 20% No.1 | 32 | $4,133 |
| Sodium Chloride0.9 % Sodium Chloride | 34 | $620 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Orange
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.